Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection

Serologic assays have become increasingly available for surveillance through the Food and Drug Administration emergency use authorization in the ongoi...

Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses

In December 2019, the first COVID-19 case, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China.

False negative rate of COVID-19 PCR testing: a discordant testing analysis

COVID-19 is diagnosed via detection of SARS-CoV-2 RNA using real time reverse-transcriptase polymerase chain reaction (rtRT-PCR) Performance of many S...

Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia

Since COVID-19 pandemic is a global crisis, tests with high sensitivity and specificity are crucial for the identification and management of COVIid-19...

A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations

Comparative assessments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular assays are warranted to assess real-world performanc...

Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program

Plasma collection began in two Brazilian hospitals for treatment of severe/critical patients. Donor's weight, days between disease onset and serial pl...